Liver transplantation Surgery
Conditions
Interventions
After giving consent and completing a baseline questionnaire, participating patients (clinically stable patients who received a liver transplant between 1 and 5 years previously) will be randomised in
Sponsors
University of Birmingham
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Have had a liver transplant at least 1 year and no more than 5 years prior to study baseline 2. Aged 18 or over 3. Considered clinically stable by their consultant 4. Have access to myhealth@QEHB patient portal (or agree to sign up) 5. Able to arrange for clinical testing (blood tests, weight and blood pressure) to be undertaken locally at a GP practice or dialysis centre and the results uploaded to myhealth@QEHB prior to myVirtualClinic appointment 6. Have access to a computing device (e.g. desktop computer or laptop) running an operating system compatible with the virtual clinic software, as well as camera and internet connection 7. Able to consent to participate in the study
Exclusion criteria
Exclusion criteria: 1. Unable to speak and/or read English 2. Unable to comply with study follow-up procedure (completion of electronic questionnaires) 3. Involvement in another research study or clinical trial involving ongoing questionnaire completion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The combined satisfaction score for three domains of the RAND modified Visit-Specific Satisfaction Instrument (VSQ-9) (convenience of location, getting through to the office by phone and length of time waiting). The VSQ-9 asks participants to rate their satisfaction with various aspects of their clinic appointment on a 5-point scale (poor, fair, good, very good, excellent). Scores are then transformed into a 0-100 linear scale where higher scores denote higher levels of satisfaction. VSQ-9 data will be collected at baseline and after every virtual clinic or face-to-face appointment via patient questionnaires. A difference of 10 points between the intervention and control groups in the three selected domains of the VSQ-9 at study end (12 months) will be taken as clinically significant. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Patient reported health-related quality of life measured through EQ-5D-5L patient questionnaires at baseline, 6 months and end of study 2. Patient satisfaction scores in the other six VSQ-9 domains not forming part of the primary outcome measure. Measured through patient questionnaires at baseline, 3 months (if applicable), 6 months, 9 months (if applicable) and 12 months 3. Routinely collected clinical outcomes collected via patient records at study end 4. Number and length of clinical contacts, instances of appointment non-attendance, collected via routinely collected metrics, clinician reporting throughout the study 5. Health service use, collected via patient questionnaires at baseline and end of study 6. Patient costs, collected via patient questionnaires at baseline, 3 months (if applicable), 6 months, 9 months (if applicable), 12 months 7. Secondary care costs, collected via routinely collected data at study end 8. MyVirtualClinic system performance, collected via routinely collected metrics at study end 9. Whether patients in the intervention arm have been able to have clinical tests carried out locally prior to their virtual clinic appointment, collected via clinician-completed case report form after each appointment 10. Patient, carer and clinician experience of the study, collected via semi-structured interviews at the end of the study 11. Questionnaire completion rates, assessed using information on the proportion of questionnaires completed by participating patients at the end of the study 12. Participants' travel requirements, assessed using patient questionnaire at baseline | — |
Countries
England, United Kingdom
Contacts
Public ContactElaine O'Connell-Francischetto
Outcome results
None listed